The estimated Net Worth of Federica F. O'brien is at least $56.6 mil dollars as of 20 May 2024. Ms. brien owns over 4,500 units of TELA Bio stock worth over $11,880 and over the last 4 years she sold TELA stock worth over $0. In addition, she makes $44,695 as Independent Director at TELA Bio.
Federica has made over 1 trades of the TELA Bio stock since 2024, according to the Form 4 filled with the SEC. Most recently she exercised 4,500 units of TELA stock worth $11,880 on 20 May 2024.
The largest trade she's ever made was exercising 4,500 units of TELA Bio stock on 20 May 2024 worth over $11,880. On average, Federica trades about 409 units every 0 days since 2020. As of 20 May 2024 she still owns at least 4,500 units of TELA Bio stock.
You can see the complete history of Ms. brien stock trades at the bottom of the page.
Federica F. OBrien CPA serves as Independent Director of the Company. Ms. O'Brien has over 25 years of executive financial and operational leadership roles in life sciences and technology companies. Ms. O'Brien has held senior executive and financial leadership roles at Complexa, Inc., Cerecor, Inc., Cervilenz, Inc., Cardiokine, Inc., and Barrier Therapeutics, Inc. Earlier in her career, Ms. O'Brien was Chief Financial Officer of Infonautics, Inc., a publicly-held technology-based company. Currently, Ms. O'Brien is President of CFO'Brien Consulting, LLC, for which she provides strategic and financial consulting services for life sciences companies. Ms. O'Brien began her career in professional service accounting firms, most recently at PricewaterhouseCoopers, where she was dedicated to emerging growth companies. Ms. O'Brien received her B.A. in accounting from Rutgers University and is a Certified Public Accountant.
As the Independent Director of TELA Bio, the total compensation of Federica OBrien at TELA Bio is $44,695. There are 7 executives at TELA Bio getting paid more, with Antony Koblish having the highest compensation of $2,399,600.
Federica OBrien is 62, she's been the Independent Director of TELA Bio since 2019. There are 1 older and 13 younger executives at TELA Bio. The oldest executive at TELA Bio, Inc. is Maarten Persenaire, 63, who is the Co-Founder, Chief Medical Officer.
Federica's mailing address filed with the SEC is C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA, 19355.
Over the last 5 years, insiders at TELA Bio have traded over $4,222,376 worth of TELA Bio stock and bought 4,343,227 units worth $46,898,981 . The most active insiders traders include Management Inc. Opaleye, Investments, Lpwong Roderic... y Advisors Llc Orbi Med Capit.... On average, TELA Bio executives and independent directors trade stock every 18 days with the average trade being worth of $139,070. The most recent stock trade was executed by Advisors Llc Orbi Med Capit... on 28 June 2024, trading 428,300 units of TELA stock currently worth $2,021,576.
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
TELA Bio executives and other stock owners filed with the SEC include: